MGH Cancer Center Grand Rounds 2023-2024 – Subscription
Massachusetts General Hospital
Cancer Center Grand Rounds 2023-2024
September 7, 2023 – May 30, 2024
For the first time ever, the 2023-2024 Cancer Center Grand Rounds are available to the public to attend virtually LIVE via paid subscription.
(Please note: This subscription does not include in-person attendance)
The theme of the series is “Women in Cancer: and kicks off Thursday September 7, 2023 at 12:00 PM EDT. with the annual “Chabner Pioneers in Oncology Lectureship”. The series will cover a comprehensive array of disease areas and topics, attendees will be provided with a robust selection of sessions to bring them up to speed on the most cutting-edge research and therapies in oncology.
The subscription will provide access to BOTH the live webinar AND the recording; however, if claiming credit, you may only claim credit for attending one or the other per date.
Target audience
This activity is intended for research and clinical staff who need to be educated on cutting edge information on advances and perspectives on cancer research and treatment across the full spectrum of cancer specialization.
Learning objectives
Upon completion of this activity, participants will be able to:
- Evaluate recent advances or controversies in hematology/oncology treatment, clinical research and/or basic science investigation presented in this series
- Assess opportunities to integrate information, tools or practices presented in this conference into how you deliver or support research and patient care
- Apply new information or perspectives from this conference into specific aspects of your responsibilities in patient care, research or the system in which you work.
- Recognize evolving landscape of cancer care worldwide
Registration instructions
Registration Type | Tuition Price |
---|---|
All Other Healthcare Providers | $250.00 |
Fellows | $50.00 |
For questions regarding the registration process, please contact Mass General Brigham Office of Continuing Professional Development at partnerscpd@partners.org.
Additional information
Massachusetts General Hospital Cancer Center and Mass General Brigham
Faculty credentials
Colin D. Weekes, MD, PhD – Course Director
Director, Medical Oncology Research for Pancreatic Cancer,
Director, Cancer Center Grand Rounds Program
Massachusetts General Hospital
Accreditation
Accreditation
In support of improving patient care, Mass General Brigham is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Credit Designation Statements
AMA PRA Category 1 CreditTM
Mass General Brigham designates this live activity for a maximum of 1 AMA PRA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nursing
Mass General Brigham designates this activity for 1 ANCC contact hour. Nurses should only claim credit commensurate with the extent of their participation in the activity.
Program
Sessions will be held weekly on Thursday from September 7, 2021 to May 30, 2022 from 12:00 to 1:00 PM.
September 7, 2023
The Chabner Pioneers in Oncology Lectureship – Precision Medicine for Primary and Metastatic Brain Tumors: From Bench to Bedside (and Back to Bench)
Priscilla Brastianos, MD
Mass General Cancer Center
September 28, 2023
(This session will be available to view LIVE ONLY. There will be no recording for this session.)
Structure and Function of Mammalian SWI/SNF Chromatin Remodeling Complexes in Cancer
Cigall Kadoch, PhD
Dana-Farber Cancer Institute
October 5, 2023
Talk Title Novel Therapeutics in Gynecologic Cancers
Roisin O’Cearbhaill, MD
Memorial Sloan-Kettering Cancer Center
October 12, 2023
Women in Cancer: Navigating the Glass Ceiling
Lisa Butterfield, PhD
University of California San Francisco
Kornelia Polyak, MD, PhD
Dana-Farber Cancer Institute
Noopur Raje, MD
Mass General Cancer Center
November 9, 2023
Achieving Success as A Square Peg in the Round Hole of Academic Medicine
Jennifer Temel, MD
Mass General Cancer Center
November 30, 2023
Female Participant Engagement in Cancer Research: Sample Programs from the Field to a Pandemic
Lourdes Baezconde-Garbanati, PhD
University of Southern California
December 7, 2023
The Dobbs Decision: Implications for Women’s Health and Cancer Care
Lisa Barroilhet, MD
University of Wisconsin School of Medicine and Public Health
December 14, 2023
Targeted Therapy for Premenopausal Early Breast Cancer: A 100 Year Old Strategy
Sandra Swain, MD
Georgetown University Medical Center
Spring 2024 Grand Rounds Schedule
January 4, 2024
ASH Update
Classical Heme (Jonathan Carlson)
Leukemia (Rupa Narayan)
Lymphoma (Jake Soumerai)
Myeloma (Diana Cirstea)
BMT (Richard Newcomb)
Cell Therapy (Mark Leick)
January 11, 2024
Integrating Clinical and Laboratory Research to Identify Mechanisms of Response and Resistance to Immune Checkpoint Therapy
Padmanee Sharma, MD, PhD
MD Anderson Cancer Center
January 18, 2024
From the Ether Dome to Seldin Plaza: My Path in Renal Cell Carcinoma
Tian Zhang, MD
UT Southwestern Medical Center
January 25, 2024
Can’t Stop, Won’t Stop: The Development of New Therapies, and New Trialists, Toward a Future of Cure
Janice Mehnert, MD
NYU Langone Health
February 8, 2024
Advocacy in Oncology: Connecting What Matters with Our Science and Care
Pamela Kunz, MD
Yale School of Medicine
February 29, 2024
Brain Metastases of Breast Cancer
Patricia Steeg, PhD
National Institutes of Health
March 14, 2024
Rethinking Radiation Oncology Using HPV Driven Oropharyngeal Carcinoma as a Model
Nancy Lee, MD, FASTRO
Memorial Sloan Kettering Cancer Center
March 21, 2024
Bridging the GAP While Shattering Ceiling
Rachna Shroff, MD, MS, FASCO
University of Arizona Cancer Center
March 28, 2024
Porphyria: New Therapies and Research
Rebecca Karp, MD
Massachusetts General Hospital
Amy Dickey, MD, MSc
Massachusetts General Hospital
April 25, 2024
Treating AML in 2024 : Individualizing Treatment Approaches with Novel Therapies
Courtney DiNardo, MD, MSCE
MD Anderson Cancer Center
-
Formats
Live, On-demand, Virtual -
Price
$250.00 - This course is closed.